Publications

Publications on Pentaisomaltose®

  • Low molecular weight carbohydrate Pentaisomaltose may replace DMSO as a safer cryoprotectant for cryopreservation of peripheral blood stem cells, Svalgaard JD. et. Al, Transfusion 2016
    Link to article

Other Publications

  • Safety of dextran in relation to other colloids-ten years’ experience with hapten inhibition, Ljungstrom KG, 1993
    Link to article

 

 

Pharmacosmos


Pharmacosmos is one of the world leaders within production and fractionation of carbohydrates in particular Dextran. Pharmacosmos has an unique water-based technology and production platform for polymer fractioning and derivative synthesis.


Approved

Pharmacosmos is the only dextran manufacturer holding certificates from the US FDA and European Directorate for the Quality of Medicines (EDQM)

Quality Delivered

Pharmacosmos delivers a unique dextran quality through a production technology that completely avoids the use of organic solvents and a quality system that meets the strictest cGMP standards for human medicines

Global Service

Pharmacosmos sells and ships directly to clients everywhere in the World. We deliver Pharmaceutical Quality Dextran of the highest standards, including those of the European Pharmacopoeia (EP), the United States Pharmacopoeia (USP), and the Japanese Pharmacopoeia (JP).